Avectin

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAvectin
Drug Alias Namegene therapy (Applied Immune Sciences)
ClassificationBiologics
Mechanisms of ActionIL2 gene transference
TargetsInterleukin-2
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApplied Immune Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApplied Immune SciencesRhone Poulenc Rorer Sa
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A